fig6

Figure 6. Redrawn from Bartelena et al, New England J. of Medicine, 338:73-78,1998.Patients with Graves’ Disease were followed on methimazole, or given 131-I, or 131-I with prednisone 0.4-0.5mg/kg starting 2 or 3 days after 131-I treartment, and continuing for one month, after which the dose was tapered. Patients are grouped according to those who worsened, were unchanged, or improved during each treatment during 12 months.